Protein Changes in Serum of Endometrial Hyperplasia and Carcinoma Patients
Author Information
Author(s): Wang Yi-sheng, Cao Rui, Jin Hong, Huang Yi-ping, Zhang Xiao-yan, Cong Qing, He Yi-feng, Xu Cong-jian
Primary Institution: Fudan University
Hypothesis
Can protein expression changes in serum serve as biomarkers for endometrial hyperplasia and carcinoma?
Conclusion
The differentially expressed proteins identified may be useful as biomarkers for diagnosing and monitoring endometrial hyperplasia and carcinoma.
Supporting Evidence
- 74 proteins were identified and quantified in serum samples from endometrial lesion patients and healthy women.
- 12 proteins showed significantly altered expression levels in at least one disease group compared with healthy women.
- 7 proteins were found to be differentially expressed in atypical endometrial hyperplasia for the first time.
Takeaway
Doctors can find special proteins in the blood of women with certain types of uterine problems, which might help them diagnose these issues without needing surgery.
Methodology
Quantitative proteomics analysis using iTRAQ technology and LC-MS/MS on serum samples from patients with different stages of endometrial hyperplasia and carcinoma.
Potential Biases
Potential bias due to the exclusion of patients with metabolic disorders.
Limitations
The study may not account for all variables affecting protein expression, and the sample size is relatively small.
Participant Demographics
20 patients with endometrial lesions (6 SEH, 4 CEH, 4 AEH, 6 ECa) and 7 healthy women, median ages ranging from 33 to 53.
Statistical Information
P-Value
0.09
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website